Abstract
This report analyzes the worldwide markets for Asthma Therapeutics in US$
Million. The major therapeutic segments analyzed are Inhaled corticosteroids,
Short acting beta agonists, Long acting beta agonists, Combinations, and Anti-
leukotrienes. The report provides separate comprehensive analytics for the
USA, Canada, Japan, Europe and Rest of World. Annual forecasts are provided
for each region for the period of 2000 through 2010. The report profiles 70
companies including many key and niche players worldwide such as Abbott
Laboratories, ALTANA Pharma AG, AstraZeneca, Boehringer Ingelheim, Genentech,
Inc., GlaxoSmithKline, Merck & Co., Inc., Novartis Pharma AG, Pfizer Inc.,
Schering-Plough Corporation and 3M. Market data and analytics are derived from
primary and secondary research. Company profiles are mostly extracted from URL
research and reported select online sources.
View Cart
